NuVasive Settles Patent Litigation With Medtronic
NuVasive has agreed to settle its ongoing patent litigation with Medtronic and some of its subsidiaries. Jul 01, 2016
CoreLink Partners with The Stephens Group
The Stephens Group, a private investment firm, announced that it finalized its partnership with CoreLink. Terms of the transaction were not disclosed. Jun 30, 2016
Phygen Receives U.S. Patent for Interspinous Device
Phygen received U.S. Patent Number 9,387,016 for its interspinous device, the La Costa SnaplokISP. Jun 29, 2016
Amendia Launches Ceresâ„¢ Midline Cervical Plate
Amendia launched the Ceres™ Midline Cervical Plate, intended for anterior screw fixation of the cervical spine as an adjunct to fusion. The system designed for one and two-level surgeries and is available in 18 different length sizes. Jun 29, 2016
Benvenue Announces 500th Spinal Fusion with Luna® 3D Interbody Fusion System
Benvenue Medical announced that >500 patients have been treated to date with the Luna® 3D Interbody Fusion System. Jun 29, 2016
OrthoPediatrics Launches PediLoc Infant Locking Proximal Femur Plate
OrthoPediatrics launched the PediLoc® Infant Locking Proximal Femur Plating System to treat pediatric hip deformity or trauma. The infant-sized plates round out the company’s PediLock portfolio to address stages from infant, child to adolescent. Jun 28, 2016
Zimmer Biomet Celebrates 40th Anniversary of Oxford® Partial Knee System
Zimmer Biomet announced the 40th anniversary of the Oxford® Partial Knee, reportedly the most widely used and clinically proven partial knee replacement in the world. Jun 28, 2016
Safe Orthopaedics Expands into Latin America
Safe Orthopaedics announced its expansion into Latin America under distribution agreements covering Chile and Mexico. Jun 27, 2016
Cytori Cell Therapy Receives Limited Approval in Japan
Cytori Therapeutics announced approval for Cytori Cell Therapy™ under the Japanese Act on the Safety of Regenerative Medicine. Jun 27, 2016
Carmell Awarded U.S. Patent for Plasma-based Materials in Drug Delivery
Carmell Therapeutics received U.S. Patent No. 9,364,503, broadly covering the use of plasma-based materials to deliver drugs and proteins to an injured site. Jun 24, 2016
